Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)

Med Clin North Am. 2011 Jan;95(1):87-100. doi: 10.1016/j.mcna.2010.08.013.

Abstract

Male lower urinary tract symptoms, benign prostatic hyperplasia, enlargement of the prostate, and bladder outlet obstruction are common among aging men and will increase in socioeconomic and medical importance at a time of increased life expectancy and aging of the baby boomer generation. This article reviews the epidemiology, management, and therapeutic options for these conditions. In patients bothered by moderate to severe symptoms, providers can make educated and differential choices between several classes of drugs, alone or in combination, to treat effectively and improve the symptoms in most men. Despite the efficacy of medical therapy, there will be patients who require referral to a urologist either early, to rule out prostate cancer and other conditions, or later, after initial medical therapy and lifestyle management has failed. Perhaps as many as 30% of patients fail to achieve sufficient symptom improvement with medication, lifestyle adjustment, and fluid management, and may require more invasive or surgical treatment options.

Publication types

  • Review

MeSH terms

  • 5-alpha Reductase Inhibitors / therapeutic use
  • Adrenergic alpha-Antagonists / therapeutic use
  • Humans
  • Male
  • Muscarinic Antagonists / therapeutic use
  • Plant Extracts / therapeutic use
  • Primary Health Care*
  • Prostate-Specific Antigen
  • Prostatic Hyperplasia / complications
  • Prostatic Hyperplasia / drug therapy*
  • Prostatic Hyperplasia / therapy
  • Serenoa
  • Urinary Incontinence / drug therapy*
  • Urinary Incontinence / etiology
  • Urinary Incontinence / therapy

Substances

  • 5-alpha Reductase Inhibitors
  • Adrenergic alpha-Antagonists
  • Muscarinic Antagonists
  • Plant Extracts
  • Prostate-Specific Antigen
  • saw palmetto extract